CellaVision
Logotype for CellaVision

CellaVision (CEVI) investor relations material

CellaVision Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for CellaVision
Q4 2025 earnings summary5 Feb, 2026

Executive summary

  • Q4 2025 delivered strong results with 12.2% organic sales growth, driven by robust performance in the Americas and EMEA, while APAC was softer due to tough prior-year comparables.

  • Full-year 2025 saw 9% organic growth and net sales of SEK 759 million, with strategic milestones including CE Mark approval for the Bone Marrow Aspirate Application and a major software upgrade.

  • The Board proposes increasing the dividend to SEK 2.75 per share for 2025, up from SEK 2.5.

  • EBITDA margin for Q4 was 33%, with profit before tax rising to SEK 55 million.

  • Appointment of Monica Jönsson as CFO effective December 12, 2025.

Financial highlights

  • Q4 net sales rose 5.6% to SEK 197 million, with organic growth of 12.2% after a -6.6% FX headwind.

  • EBITDA for Q4 was SEK 65 million (33% margin); full-year EBITDA was SEK 241 million (32% margin).

  • Gross margin for Q4 was 67%, slightly lower due to software mix and FX effects; full-year gross margin was 68%.

  • Operating cash flow for Q4 was SEK 51 million; year-end cash position was SEK 188 million with low debt.

  • Earnings per share for Q4 were SEK 1.79; full-year EPS was SEK 6.42.

Outlook and guidance

  • Strong momentum in the Americas is expected to continue into H1 2026, with no signs of slowdown.

  • Bone Marrow Aspirate Application launch planned for Q1 2026 in Europe, with sales expected in H2 2026.

  • Methanol-free reagent launch in the U.S. is planned for 2026, with incremental revenue expected late in the year.

  • Gradual roll-out of the new Digital Cell Morphology Software throughout 2026.

  • Continued high R&D costs are expected in 2026, in line with earlier quarters.

BMA Application market potential
APAC sales recovery outlook for 2026
Gross margin trend and sales mix impact
Outlook for R&D spend and capitalization in 2026
FPM technology's potential beyond hematology
DC-1 momentum in US integrated health networks
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next CellaVision earnings date

Logotype for CellaVision
Q1 202624 Apr, 2026
CellaVision
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next CellaVision earnings date

Logotype for CellaVision
Q1 202624 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

CellaVision AB offers systems for automated and digital analysis of body fluids in health care services sector. It provides digital solutions for blood and body fluids analysis; image-based systems for microscopic analysis and clinical review of body fluids, such as peripheral blood film, and urine analysis; lab automation solutions; and software solutions, including Cellavision DM96, a complete solution that consists of an analyzer, instrument camera, computer, software environment with proprietary algorithms, ready-to-use reagents, and quality control material. The company also has integration solutions to hospital information systems and other laboratory systems. CellaVision AB was incorporated in 1994 and is headquartered in Lund, Sweden.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage